Pfizer

Los Angeles: The BA.2 sub-lineage of the Omicron variant now makes up about 35 per cent of new Covid-19 infections in the US, according to the data updated Tuesday by the US Centers for Disease Control and Prevention (CDC).This data is up…

New York: Evidence is mounting to show that organ donation from dying donors testing positive for SARS-CoV-2 appears to be safe and does not cause Covid-19 in the patient receiving the donated organ, according to a study. The Covid pandemic…

New York : Pregnant patients who tested positive for the coronavirus were found to have more than double the risk of poor outcomes including preterm birth, blood clot, according to a study that emphasised the need to promote maternal…

London : People who have had Covid-19 are at increased risk of developing Type 2 diabetes, according to a study.The study, published in the journal Diabetologia, showed that patients with Covid-19 developed Type 2 diabetes more frequently…

Washington : The global coronavirus caseload has topped 472 million, while the deaths have surged to more than 6.09 million and vaccinations to over 10.80 billion, according to the Johns Hopkins University.In its latest update on Tuesday…

Copenhagen/Athens : A new program launched by the World Health Organization's (WHO) Regional Office for Europe in cooperation with the Greek government will place the support for and promotion of the quality of mental health care for…

Washington : The Covid-19 pandemic is not over and the US is soon likely to see an uptick in cases due to the BA.2 subvariant of Omicron, according to the country's infectious disease expert Anthony Fauci.Fauci said that the BA.2 subvariant…

New York : An antiviral drug, developed by Pfizer to treat SARS-CoV-2, remains effective against the newest variants of the evolving Covid-19 virus, according to researchers.Researchers from the Rutgers University in the US showed that the…

Washington : The global coronavirus caseload has topped 470.6 million, while the deaths have surged to more than 6.07 million and vaccinations to over 10.79 billion, according to the Johns Hopkins University.In its latest update on Monday…

New Delhi : The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of Covid vaccine Covishield to 8 to 16 weeks in view of ongoing Omicron pandemic, said a source on…